These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 11318969

  • 21. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
    De Vecchi AF, Bamonti F, Novembrino C, Ippolito S, Guerra L, Lonati S, Salini S, Aman CS, Scurati-Manzoni E, Cighetti G.
    Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
    [Abstract] [Full Text] [Related]

  • 22. Oxidant stress in nephrotic syndrome: comparison of F(2)-isoprostanes and plasma antioxidant potential.
    Dogra G, Ward N, Croft KD, Mori TA, Barrett PH, Herrmann SE, Irish AB, Watts GF.
    Nephrol Dial Transplant; 2001 Aug; 16(8):1626-30. PubMed ID: 11477165
    [Abstract] [Full Text] [Related]

  • 23. Plasma esterified F2-isoprostanes and oxidative stress in newborns: role of nonprotein-bound iron.
    Signorini C, Perrone S, Sgherri C, Ciccoli L, Buonocore G, Leoncini S, Rossi V, Vecchio D, Comporti M.
    Pediatr Res; 2008 Mar; 63(3):287-91. PubMed ID: 18287967
    [Abstract] [Full Text] [Related]

  • 24. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation].
    Liang M, Wang L, Hou FF, Liu J, Liu ZQ, Tian JW.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896
    [Abstract] [Full Text] [Related]

  • 25. The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients.
    Sezer MT, Akin H, Demir M, Erturk J, Aydin ZD, Savik E, Tunc N.
    J Nephrol; 2007 Aug; 20(2):196-203. PubMed ID: 17514624
    [Abstract] [Full Text] [Related]

  • 26. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease.
    Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, Triantos A, Vavatsi-Christaki N, Grekas DM.
    Am J Nephrol; 2008 Aug; 28(3):397-404. PubMed ID: 18063858
    [Abstract] [Full Text] [Related]

  • 27. Time course and dose response of alpha tocopherol on oxidative stress in haemodialysis patients.
    Reed A, Cho YJ, Coombes JS, Fassett RG.
    BMC Nephrol; 2009 Oct 22; 10():32. PubMed ID: 19845969
    [Abstract] [Full Text] [Related]

  • 28. Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients.
    Pernice F, Floccari F, Nostro L, Caccamo C, Belghity N, Mantuano S, Romeo A, Barilla' A, Aloisi C, Ruello A, Frisina N, Buemi M.
    J Nephrol; 2006 Oct 22; 19(5):613-20. PubMed ID: 17136690
    [Abstract] [Full Text] [Related]

  • 29. Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.
    Hodkova M, Dusilova-Sulkova S, Kalousova M, Soukupova J, Zima T, Mikova D, Malbohan IM, Bartunkova J.
    Ren Fail; 2006 Oct 22; 28(5):395-9. PubMed ID: 16825088
    [Abstract] [Full Text] [Related]

  • 30. Enhanced oxidative stress with a gradient between plasma and muscle interstitial fluid in patients with end stage renal failure on hemodialysis.
    Karamouzis I, Grekas D, Karamouzis M, Triantos A, Vasileva-Staikova S, Kovachev D, Dimitriadou A.
    Hormones (Athens); 2008 Oct 22; 7(1):62-9. PubMed ID: 18359745
    [Abstract] [Full Text] [Related]

  • 31. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
    Tarng DC, Huang TP, Wei YH, Liu TY, Chen HW, Wen Chen T, Yang WC.
    Am J Kidney Dis; 2000 Nov 22; 36(5):934-44. PubMed ID: 11054349
    [Abstract] [Full Text] [Related]

  • 32. Factors of microinflammation in non-diabetic chronic kidney disease: a pilot study.
    Olivier V, Dunyach-Remy C, Corbeau P, Cristol JP, Sutra T, Burtey S, Lavigne JP, Moranne O.
    BMC Nephrol; 2020 Apr 21; 21(1):141. PubMed ID: 32316931
    [Abstract] [Full Text] [Related]

  • 33. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
    Dashti N, Einollahi N, Nabatchian F, Moradi Sarabi M, Zarebavani M.
    Acta Med Iran; 2012 Apr 21; 50(3):197-202. PubMed ID: 22418989
    [Abstract] [Full Text] [Related]

  • 34. Elevated plasma levels of F2 alpha isoprostane in cystic fibrosis.
    Collins CE, Quaggiotto P, Wood L, O'Loughlin EV, Henry RL, Garg ML.
    Lipids; 1999 Jun 21; 34(6):551-6. PubMed ID: 10405967
    [Abstract] [Full Text] [Related]

  • 35. Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes.
    Devaraj S, Hirany SV, Burk RF, Jialal I.
    Clin Chem; 2001 Nov 21; 47(11):1974-9. PubMed ID: 11673365
    [Abstract] [Full Text] [Related]

  • 36. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.
    Schweer H, Watzer B, Seyberth HW, Nüsing RM.
    J Mass Spectrom; 1997 Dec 21; 32(12):1362-70. PubMed ID: 9423285
    [Abstract] [Full Text] [Related]

  • 37. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
    Elshamaa MF, Sabry S, Nabih M, Elghoroury EA, El-Saaid GS, Ismail AA.
    Ann Nutr Metab; 2009 Dec 21; 55(4):309-16. PubMed ID: 19828941
    [Abstract] [Full Text] [Related]

  • 38. [Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogene].
    Yu YM, Hou FF, Zhang X, Zhou H, Liu ZQ.
    Zhonghua Nei Ke Za Zhi; 2004 Apr 21; 43(4):292-5. PubMed ID: 15130417
    [Abstract] [Full Text] [Related]

  • 39. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
    Tarng DC, Huang TP, Liu TY, Chen HW, Sung YJ, Wei YH.
    Kidney Int; 2000 Aug 21; 58(2):790-9. PubMed ID: 10916104
    [Abstract] [Full Text] [Related]

  • 40. Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose.
    Conner TA, McQuade C, Olp J, Pai AB.
    Biometals; 2012 Oct 21; 25(5):961-9. PubMed ID: 22706571
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.